Anupam Rasayan India Limited has informed that on September 28, 2026 it has completed acquisition of Bliss GVS Pharma Limited and has been designated as promoter with effect from September 28, 2026. Along with PAC Mates Visa Consultancy Private Limited, the acquirer now holds 5,32,36,264 equity shares representing 50.07 percent of Bliss equity share capital.
This follows Share Purchase Agreement dated 23 May 2026 with sellers and deed of adherence dated 17 July 2026 with PAC pursuant to open offer. Open offer tender of 1,669 shares was credited on 24 August 2026. On 28 September 2026, Anupam Rasayan acquired further 22,50,000 shares through on-market transaction.
At A Glance - Key Highlights
- Acquirer: Anupam Rasayan India Limited with PAC Mates Visa Consultancy
- Target: Bliss GVS Pharma Limited, manufacturer of pharma products like suppositories, pessaries, tablets, capsules
- Control: 50.07 percent, 5,32,36,264 shares, designated as promoters from Sept 28, 2026
- SPA Shares: 5,09,84,595 shares, 47.95 percent completed on Sept 28, 2026
- On Market Purchase: 22,50,000 shares, 2.12 percent at Rs 723.2883 per share, aggregate Rs 162.73 Crores
- Open Offer: 1,669 shares by acquirer and 1,699 shares by PAC
Why Bliss GVS
Bliss GVS is a public listed company incorporated on 11 December 1984 with global footprint in over 60 countries, dominant market SubSaharan Africa. It makes niche dosage forms with differentiated brands and strong international presence.
Anupam Rasayan said acquisition will strengthen its presence across pharmaceutical value chain spanning KSMs to finished dosage formulations, combining its advanced chemistry capabilities with Bliss capabilities to create integrated and diversified manufacturing platform with forward integration and synergies.
Financials Of Target
Turnover as on March 31, 2026 consolidated is Rs 1000,64,26,000 and Net worth is Rs 1231,76,00,000. Last three years turnover is Rs 1000.64 Crores in FY 2023-24, Rs 846.21 Crores in FY 2024-25 and Rs 798.98 Crores in FY 2025-26.
Cash consideration only for on market purchase at Rs 723.2883 per share. Total holding now 50.07 percent gives control of Bliss.
Acquisition Details In Table
| Point | Details |
|---|---|
| Target Company | Bliss GVS Pharma Limited, incorporated Dec 11, 1984, pharma manufacturing, 60 plus countries |
| Shares Acquired On Sept 28 | 22,50,000 shares, 2.12 percent, Rs 723.2883 per share, Rs 162.73 Crores aggregate |
| SPA Completion | 5,09,84,595 shares, 47.95 percent completed on Sept 28, 2026 |
| Total Holding | 5,32,36,264 shares, 50.07 percent with PAC, control acquired, designated promoter from Sept 28, 2026 |
| Turnover | FY26 consolidated Rs 1000.64 Crores, FY25 Rs 846.21 Crores, FY26 Rs 798.98 Crores, net worth Rs 1231.76 Crores |
Conclusion
In short, Anupam Rasayan India on September 28, 2026 completed acquisition of Bliss GVS Pharma with 50.07 percent holding including 47.95 percent via SPA and 2.12 percent via on-market Rs 723 per share deal worth Rs 162.73 crores, gaining control and becoming promoter to build integrated pharma platform from KSMs to finished dosages with global reach.